News | December 07, 2022
Global procalcitonin tests market set to surpass $2 billion in 2030: GlobalData
The use of procalcitonin testing for sepsis management is highest in the US
The use of procalcitonin testing for sepsis management is highest in the US
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
Soluplus branded excipient play a critical role in enabling the drug development process for poorly soluble active pharmaceutical ingredients
Move to increase affordability and accessibility for heart failure patients across the country
The service includes full fertility care benefits, including egg and embryo freezing options to employees
Presentations include new data on investigational medicines – favezelimab (MK-4280), zilovertamab vedotin (MK-2140) and nemtabrutinib – as well as KEYTRUDA (pembrolizumab) in multiple blood cancers
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
Shilpa Medicare Ltd's finished dosage form manufacturing facility, Unit IV, situated at Pharma SEZ, Jadcherla, Telangana has received Health Canada GMP approval
Subscribe To Our Newsletter & Stay Updated
